Global demand for Ozempic has skyrocketed, in part because of prescriptions related to weight loss.
Health Canada said it recommends that prescribers: Do not start new patients on these drugs that are in shortage, unless there are no suitable alternatives and there's a clinical reason to do so. Consider prescribing an alternative drug for patients taking one of these drugs that are in shortage, as a continuous supply can't be guaranteed. Conserve the existing supply for patients who are stabilized and have no other treatment options.
[
add
]
[
|
|
...
]